Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
[ Tue, Mar 26th 2024
] - WOPRAI
Raghuram Selvaraju Reiterated (ADMA) at Strong Buy with Increased Target to $7.5 on, Mar 26th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $6 to $7.5 on, Mar 26th, 2024.
Raghuram has made no other calls on ADMA in the last 4 months.
There are 2 other peers that have a rating on ADMA. Out of the 2 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $10 on, Friday, March 1st, 2024
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $8 on, Thursday, February 29th, 2024
